Probably the same report I uploaded a month or two back - target price of 60c (without sales) and a hold recommendation. Don't want adverse publicity for RFX, yet in all your posts you constantly provide a negative outlook... You're just one big oxymoron.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution